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Abstract 
Background: The negative consequence of methamphetamine abuse is due to neuropathologic changes in the brain, 
which reduces dopaminergic neurons and result in damage to different brain areas. Neurotoxicity induced by 
methamphetamine increases the oxidative stress and associated with neuronal apoptosis. The role of the antioxidant 
coenzyme Q10 probably produces its neuroprotective effects. Therefore, the purpose of the present study was to 
examine the protective effect of coenzyme Q10 on methamphetamine-induced apoptosis in adult male rats. 
Materials and Methods: Fifty Wistar eight-week adult rats randomly divided into 5 groups: Healthy control, 
methamphetamine injection (Meth), methamphetamine injection and CoQ10 5mg/kg treatment (Meth+Post CoQ10 
5mg/kg), methamphetamine injection and CoQ10 10mg/kg treatment (Meth+Post CoQ10 10mg/kg), 
methamphetamine injection and CoQ10 20mg/kg treatment (Meth+Post CoQ10 20mg/kg). Methamphetamine with a 
purity of 96% with a dosage of 20 mg/kg was injected Intraperitoneal. Coenzyme Q10 for three treatment groups was 
injected intraperitoneally for 14 days in a dosage of 5, 10 and 20 mg/kg/day. The protein expressions of Baxand Bcl2 
were evaluated by western blotting technique. 
Results: Bax protein expression was significantly lower in Meth+Post CoQ10 5mg/kg (p=0.010) and so Meth+Post 
CoQ10 10mg/kg (p=0.004) comparing to Meth group. In addition, Bcl2 protein expression was significantly higher 
in Meth+Post CoQ10 5mg/kg comparing to Meth group (p=0.018). However, there were no significant differences 
between control and CoQ10 treatment groups. Bax/Bcl2 ratio was significantly lower in Meth+Post CoQ10 5mg/kg 
(p=0.005), Meth+Post CoQ10 10mg/kg (p=0.008) and Meth+Post CoQ10 20mg/kg (p=0.044) comparing to Meth 
group. 
Conclusion: We suggest that CoQ10 reduces the methamphetamine-induced apoptosis in the striatum of the rats 
through the reduction of apoptotic factors and increase of anti-apoptotic pathways. 
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Introduction 
Addiction and substance abuse have negative effects on 
human’s life, including physical and mental health, and 
social, legal, and emotional status
1
. Methamphetamine is 
an addictive psychoactive drug which has been proven to 
have strong stimulant effects on CNS. Its popularity is 
increasing in US and other parts of the world because of 
low price
2
. Methamphetamine abuse is becoming a 
public health problem in global level and it is estimated 
that there are 15-16 million methamphetamine abuser 
around the world, which is making it the second abused 
Gholipour et al.                                                   Protective Effect of Coenzyme Q10 on Methamphetamine-Induced Apoptosis … 
NBM                                                                                     128                                Novelty in Biomedicine 2017, 3, 127-32 
substance
3
. Euphoria caused by methamphetamine is 
accompanied by loss of appetite and body temperature, 
paranoia, aggression, and increased sense of joy
4
. In 
humans, methamphetamine abuse has cognitive and 
neurologic damages and cardiovascular complications
5
. 
Methamphetamine can pass through blood-brain barrier 
and is probably able to damage dopaminergic neurons. 
Methamphetamine injection can cause prolonged release 
of dopamine in humans and animals
6
.  
Oxidative stress, mitochondrial disruption, apoptosis, 
neural inflammation, and toxicity mediated by NMDA 
receptors are mechanisms generally mentioned in 
neurotoxicity of dopaminergic neurons
7
. Chronic abuse 
of methamphetamine causes decrease in dopamine 
transporters in cortex, caudate and putamen, and decrease 
in serotonin transporters
8
, as well as microglial activation 
in different areas of brain
9
 and morphologic changes like 
a decrease in gray matter and hypertrophy of white 
matter
10
. In many studies there are convincing evidences 
in support of methamphetamine damage to different areas 
of brain and neuron loss
10-12
. Evidences suggest that 
methamphetamine neurotoxicity involves reactive 
oxygen species (ROS), reactive nitrogen species (RNS) 
and lower-hand oxidative stress mechanisms activation
13
. 
Methamphetamine enters dopaminergic neurons via 
dopamine transporters and shifts dopamine vesicle. 
Moved amines can be oxided in enzyme and non-enzyme 
forms and makes reacting Quoinons and ROS and 
increase oxidative stress
14
. Thus, ROS causes death of 
neurons due to damage to cellular parts including DNA, 
RNA, and proteins. Also mitochondrial disruption in 
neural destruction caused by methamphetamine has been 
noticed
15
. Methamphetamine is lipophilic cation 
molecule that can infiltrate into mitochondria and stays 
there. In fact, methamphetamine reduces mitochondrial 
membrane potential and level of I, III, and VI complex of 
electron transport chain in primary human cells
16
 which 
is followed by decreased ATP in brain
17
. Pro apoptotic 
proteins like Bax, Bad and Bid are increased and anti-
apoptotic proteins like Bcl-2 and Bcl-XL are decreased 
after injection of methamphetamine
17
. Plus, 
methamphetamine not only causes cellular death via 
apoptosis, but also via necrotic mechanisms
18
. 
Studies suggest that medication modalities in order to 
prevent and treat destructive effects of methamphetamine 
need attention to pathways that form substrates of 
methamphetamine-induced toxicity. Co-enzyme Q10 is 
necessary enzyme in the electron transport chain and an 
effective agent for neuroprotection in neurodegenerative 
diseases which increases plasma levels of Q10 co-
enzyme and prevents decrease in dopamine when added 
to diet
19
. In recent years use of co-enzyme Q10 has been 
in center of attention for treatment of neurodegenerative 
diseases.co-enzyme Q10 probably acts as a 
neuroprotective agent by its anti-oxidant and free radical 
neutrizing effects. Plus that, co-enzyme Q10 is an 
electron receptor in complex I of electron transport 
chain
20
. Co-enzyme Q10 protects neurons from oxidative 
stress and prevents reduction in membrane potential of 
mitochondrial membrane
21
. Studies have shown that co-
enzyme Q10 reduces neural damage of hippocampus in 
regions CA1, CA2, and CA3. Clinical studies also 
showed that co-enzyme Q10 can protect dopaminergic 
system of striatum and slows progression of disability in 
Parkinson disease
22
. Since apoptosis caused by 
methamphetamine-induces neurotoxicity can damage 
various parts of brain, especially dopaminergic part, and 
there are findings on protective effects of co-enzyme Q10 
on neurologic system, in this survey, we study the 
protective effect of co-enzyme Q10 on apoptosis caused 
by injection on methamphetamine on adult male rat. 
Methods 
This is an experimental-interventional study on heads of 
50 adult male 8-weeks old wistar rats, weighing 200±20 
gr. Rats were housed in standard cages and controlled 
conditions of light (12 hr darkness, 12 hr light), 
temperature 22±3℃ and humidity around 45%, with free 
access to food and water. All steps were done by 
supervision of Ethics committee of Iran University of 
Medical Sciences and according to the moral protocol of 
experiments on lab animals. Samples are divided 
randomly into these five groups: Control, 
methamphetamine injection (meth), methamphetamine 
injection + post 5mg/kg co-enzyme Q10, 
methamphetamine injection + post 10mg/kg co-enzyme 
Q10, and methamphetamine injection + post 20mg/kg co-
enzyme Q10. 
Methamphetamine was obtained from police and had 
96% purity. It was solved in physiologic serum and was 
injected totally 20 mg/kg within 2 days (10 mg each day, 
5 mg 2 times a day with 12hr intervals) 
intraperitoneally
3
. For verification of injection, mobility 
test was performed. When injected, if animal passed 10 
times around a 30cm basket, an injection would be 
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considered effective. Then the Co-enzyme Q10 injection 
as a post-treatment was starting after one day from the 
last injection of Methamphetamine. Co-enzyme Q10 
provided from Sigma Co (St. louis, MO, USA) and 
solved with concentration of 100mg/cc in sesame oil. The 
solution of Co-enzyme Q10 was injected within 14 days 
in 5, 10, 20 mg/kg/day intraperitoneally for three post-
treatment groups. The control group just received 
physiologic serum without Methamphetamine but the 
same volume to Meth group. 
For the purpose of studying of expression of Bax and 
Bcl2 proteins in striatal region, the animals was 
sacrificed for provide brain tissue. All of the animals 
anesthetized by intraperitoneal injection of ketamine and 
xylazine in 8:1 proportion and after cutting their head and 
removing their brain, striatal part was dissected and 
washed by normal saline immediately and put striatal 
parts in microtubes and freeze in liquid nitrogen and then 
into a refrigerator with -80℃ and stored until western 
blotting them. Process had to done in less than 4 minutes 
after cutting head for each rat. For studying expression of 
Bax Bcl2 proteins, it was first derived and after that, 
using western blotting technique, protein bands removed 
from SDS-PAGE gel via electrophoresis were moved to a 
nitrocellulose membrane and in next step, were detected 
using primary and secondary antibodies
23
. For 
Quantitation of protein bands TotalLab Version 1.10 
software was used. Data analysis was done using SPSS 
software. All data are reported with medium ± standard 
deviation. Kolmogrof-smirnof test was done to evaluate 
normal distribution of data and if distribution was 
normal, then parametric tests were used. Difference 
between groups was studied using unilateral variance 
analysis test and Tukey. Dunnett`s T3post hoc tests was 
done to compare the groups. The level of significance 
was set at p ≤ 0.05. 
Results 
As shown in figure 1, expression of Bax protein in 
control group (p=0.012), meth +post 5mg/kg (p=0.010), 
meth + post 10mg/kg (p=0.004) was significantly less 
than Meth group. But there is no significant difference 
between meth+ post 20mg/kg and Meth (p=0.056). There 
is also no significant difference between groups which 
were treated with co-enzyme Q10 and control group 
(p>0.05). 
Expression of Bcl2 protein in meth + post 5mg/kg co-
enzyme Q10 group (p=0.018) was significantly higher 
 
 
Figure 1. Expression of Bax protein in between groups,* significant 







Figure 2. Expression of BCL2 protein in between groups,* 
significant ratio Meth group. 
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than meth group, but there was no significant difference 
between groups treated by co-enzyme Q10 and control 
group (p>0.05, figure 2). 
Ratio of Bax/Bcl2 in the control group (p=0.014), meth 
+post 5mg/kg co-enzyme Q10 (p= 0.005), meth + post 
10mg/kg co-enzyme Q10 (p=0.008), meth + post 
20mg/kg co-enzyme Q10 (p=0.044) was significantly 
lower than Meth group, but there was no significant 
difference between groups treated by co-enzyme Q10 and 
control group (p>0.05). 
Discussion 
Deep stimulation of the brain is another modality for 
treatment of addiction and various parts of brain 
including nucleus accumbens, subthalamic nucleus, 
dorsal striatum, medial prefrontal cortex, and other parts 
of the brain are targeted
24
. How the methamphetamine 
increased apoptosis induction in striatum? There are 
convincing evidences that negative psycho-neural 
consequences of methamphetamine abuse is partly 
because of pathologic neurological changes in brain of 
abusers
25
. Dopamine release caused by 
methamphetamine is oxidized by monoamine oxidase 
and dihydroxyphenil acetic acid and hydrogen peroxide 
are produced
26
. Hydrogen peroxide interacts with metal 
ions and produces highly toxic hydroxyl free radical via 
phenton reaction. Thus, reacting oxygen species (ROS) 
including hydroxyl free radicals cause neuron death via 
damage to cellular parts like DNA, RNA and proteins. 
Methamphetamine is a lipophilic cation molecule which 
can diffuse into mitochondria and stays there. 
Methamphetamine also decreases the activity of complex 
2 and 4 of electron transport chain swiftly which is 
accompanied by a decrease of ATP in brain
17
. In this 
study methamphetamine injection caused apoptosis in 
striatum which was consistent with previous studies
27
. 
This apoptosis might be because of various factors like 
oxidants, oxygen radicals and nitric oxide, which are 
originated from excessive release of glutamate and 
dopamine
28
. It is shown that methamphetamine causes an 
increase in pro apoptotic proteins like Bax, Bad and Bid, 
but decreases anti apoptotic proteins like Bcl-2 and Bcl-
Xl
17
. In this study, compatible with previous surveys, we 
demonstrated that methamphetamine induces apoptotic 
factors like Bax in rats. We also showed that induction of 
these apoptotic factors is reduced by co-enzyme Q10 
anti-oxidant. So there is probability that apoptosis of 
dopaminergic neurons in striatum of rats is reduced. How 
Co-enzyme Q10 reduced apoptosis induction? Co-
enzyme Q10 is a necessary enzyme in the electron 
transport chain and an effective neuroprotective agent in 
neurodegenerative disease. Adding co-enzyme Q10 to the 
diet increases its plasma level and prevents dopamine 
decrease
19
. It also acts as important antioxidants in 
mitochondria and lipid membranes. There is a 
remarkable interest in using co-enzyme Q10 in 
neurodegenerative diseases.co-enzyme Q10 protects 
neurons from oxidative stress and prevents reduction in 
mitochondrial membrane potential
21
. In animal models of 
Parkinson disease has protective function
29
. Co-enzyme 
Q10 also protects dopaminergic neurons from 
mitochondrial membrane depolarization and rotenone-
induced death
30
. A mechanism of co-enzyme Q10 




Co-enzyme Q10 suppresses apoptosis caused by 
oxidative stress and mitochondrial permeability
32
. It also 
stops Bax connection with mitochondria and cytochrome 
C release from mitochondria
33
. Co-enzyme Q10 
significantly reduces indices of lipid peroxidation in 
plasma, erythrocytes, liver and brain of rats
34
. So there is 
probability that in this study, co-enzyme Q10 
supplementation protects against methamphetamine-
induced dopaminergic apoptosis by increasing anti-
oxidant activity and neutralizing free radicals. It has also 




In this study, we demonstrated induction of apoptosis in 
striatum after acute injections of methamphetamine, 
because levels of Bax protein in Meth group were 
increased. Although treatment with doses of 5 and 10 of 
co-enzyme Q10 after injection of methamphetamine 
caused a decrease in Bax protein levels in comparison 
with Meth group. Probably protective effects of co-
enzyme Q10 after injection of methamphetamine is due 
to its anti-apoptotic mechanisms. In addition, to 
mentioned apoptotic factors, higher levels of Bcl-2 
protein in treatment with dose 5 of co-enzyme Q10 after 
injection of methamphetamine was observed. Also ratio 
of Bax/Bcl2 was significantly lower in groups of 
treatment with dose 5, 10 and 20 of co-enzyme Q10 in 
comparison with Meth group which is a reflection of an 
increase in anti-apoptotic status. 
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Conclusion 
Overall, the findings of this study suggest that co-enzyme 
Q10 reduces apoptosis induced by methamphetamine 
injection in striatum of rats via reduction in apoptotic 
factors like Bax and increase in anti-apoptotic pathways. 
We noticed that co-enzyme Q10 reduces apoptosis 
induction after injection of methamphetamine in male 
rats. We hope that treatment with co-enzyme Q10 after 
addiction to methamphetamine be helpful in addicted 
patients. 
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